DK2393477T3 - APPLICATION OF A GLUCOCORTICOID COMPOSITION FOR TREATMENT OF HEAVY AND UNCONTROLLED ASTMA - Google Patents
APPLICATION OF A GLUCOCORTICOID COMPOSITION FOR TREATMENT OF HEAVY AND UNCONTROLLED ASTMA Download PDFInfo
- Publication number
- DK2393477T3 DK2393477T3 DK10705986.7T DK10705986T DK2393477T3 DK 2393477 T3 DK2393477 T3 DK 2393477T3 DK 10705986 T DK10705986 T DK 10705986T DK 2393477 T3 DK2393477 T3 DK 2393477T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhalation
- approx
- aerosol
- composition
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/365,754 US20100196483A1 (en) | 2009-02-04 | 2009-02-04 | Method for treatmentof severe and uncontrollable asthma |
| PCT/EP2010/051321 WO2010089330A1 (en) | 2009-02-04 | 2010-02-03 | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2393477T3 true DK2393477T3 (en) | 2018-04-09 |
Family
ID=42153807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10705986.7T DK2393477T3 (en) | 2009-02-04 | 2010-02-03 | APPLICATION OF A GLUCOCORTICOID COMPOSITION FOR TREATMENT OF HEAVY AND UNCONTROLLED ASTMA |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20100196483A1 (pt) |
| EP (2) | EP2393477B1 (pt) |
| JP (1) | JP5886630B2 (pt) |
| KR (1) | KR20110122671A (pt) |
| CN (2) | CN102307567A (pt) |
| AU (1) | AU2010210183B2 (pt) |
| BR (1) | BRPI1008227A8 (pt) |
| CA (1) | CA2751443C (pt) |
| DK (1) | DK2393477T3 (pt) |
| ES (1) | ES2659328T3 (pt) |
| HU (1) | HUE038553T2 (pt) |
| IL (1) | IL213959A (pt) |
| MX (1) | MX2011008200A (pt) |
| NO (1) | NO2393477T3 (pt) |
| NZ (1) | NZ594210A (pt) |
| PL (1) | PL2393477T3 (pt) |
| PT (1) | PT2393477T (pt) |
| RU (1) | RU2519344C2 (pt) |
| SG (1) | SG173538A1 (pt) |
| SI (1) | SI2393477T1 (pt) |
| UA (1) | UA102587C2 (pt) |
| WO (1) | WO2010089330A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2534958A1 (en) | 2007-12-14 | 2012-12-19 | AeroDesigns, Inc | Delivering aerosolizable food products |
| US10857310B2 (en) | 2012-03-09 | 2020-12-08 | Vectura Gmbh | Mixing channel for an inhalation device and inhalation device |
| WO2014012954A1 (en) * | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
| US20140261474A1 (en) * | 2013-03-15 | 2014-09-18 | Aradigm Corporation | Methods for inhalation of smoke-free nicotine |
| WO2014204511A2 (en) | 2013-06-18 | 2014-12-24 | Isonea Limited | Compliance monitoring for asthma inhalers |
| MX2016004530A (es) | 2013-10-08 | 2017-02-13 | Lam Therapeutics Inc | Rapamicina para el tratamiento de linfangioleiomiomatosis. |
| WO2015110394A1 (en) * | 2014-01-22 | 2015-07-30 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier) |
| PL3125875T3 (pl) * | 2014-04-04 | 2023-11-20 | AI Therapeutics, Inc. | Nadający się do inhalacji preparat rapamycyny do leczenia stanów związanych z wiekiem |
| WO2015197798A1 (en) * | 2014-06-25 | 2015-12-30 | Optinose As | Nasal administration |
| EP3209330B1 (en) | 2014-10-07 | 2022-02-23 | AI Therapeutics, Inc. | An inhalable sirolimus formulation for the treatment of pulmonary hypertension |
| RU2611406C1 (ru) * | 2015-09-03 | 2017-02-21 | Общество с ограниченной ответственностью "Биосурф" (ООО "Биосурф") | Способ лечения бронхиальной астмы |
| CA3028604C (en) | 2016-07-08 | 2023-12-05 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| ES2920151T3 (es) | 2016-12-09 | 2022-08-01 | Trudell Medical Int | Nebulizador inteligente |
| EP3735287A4 (en) | 2018-01-04 | 2021-09-15 | Trudell Medical International | INTELLIGENT POSITIVE OSCILLATING EXPIRATORY PRESSURE DEVICE |
| US11712175B2 (en) | 2019-08-27 | 2023-08-01 | Trudell Medical International | Smart oscillating positive expiratory pressure device with feedback indicia |
| US11593679B2 (en) * | 2019-11-29 | 2023-02-28 | Kpn Innovations, Llc. | Method of and system for generating a longevity element and an instruction set for a longevity element plan |
| US12051492B2 (en) | 2021-01-29 | 2024-07-30 | AsthmaTek, Inc. | Systems and methods to determine a therapy regimen to treat asthma of a subject |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19720701A1 (de) * | 1997-05-16 | 1998-11-19 | Gsf Forschungszentrum Umwelt | Vorrichtung zur Applikation eines Medikament-Aerosols über die Lunge |
| US6187765B1 (en) * | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| DE19851279B4 (de) * | 1998-06-17 | 2006-05-24 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge |
| DE19912265A1 (de) * | 1999-03-18 | 2000-09-21 | Gsf Forschungszentrum Umwelt | Verfahren und Vorrichtung zur Bereitstellung einer konstanten Medikamenten-Dosis für eine inhalatorische Applikation mit niedrigem Inhalationsfluß |
| DE19912461B4 (de) * | 1999-03-19 | 2006-07-20 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zur Flußbegrenzung bei niedrigen Differenzdrücken |
| DE10013093B4 (de) * | 2000-03-17 | 2005-12-22 | Inamed Gmbh | Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole |
| DE10029119B4 (de) * | 2000-06-14 | 2005-12-22 | Institut für Aerosol Medizin InAMed GmbH | Inhalationsvorrichtung |
| DE10123749A1 (de) * | 2001-05-16 | 2002-12-12 | Inamed Gmbh | Vorrichtung zum Verabreichen von Aerosolen |
| KR20070007075A (ko) * | 2003-12-31 | 2007-01-12 | 사이덱스 인크 | 술포알킬 에테르 시클로덱스트린 및 코르티코스테로이드를함유한 흡입용 제형 |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| ES2414869T3 (es) * | 2005-03-08 | 2013-07-23 | Activaero Gmbh | Dispositivo de inhalación |
| ES2290827T3 (es) * | 2005-07-06 | 2008-02-16 | Activaero Gmbh | Valvula regulable y dispositivo para inhalar. |
| KR100802292B1 (ko) * | 2006-07-21 | 2008-02-11 | 동부일렉트로닉스 주식회사 | 마스크 및 이를 이용한 마이크로 렌즈 제작 방법 |
| CN101795565A (zh) * | 2007-06-28 | 2010-08-04 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| US20100092397A1 (en) * | 2008-10-14 | 2010-04-15 | Activaero Gmbh | Method For Treatment of COPD and Other Pulmonary Diseases |
-
2009
- 2009-02-04 US US12/365,754 patent/US20100196483A1/en not_active Abandoned
-
2010
- 2010-02-03 WO PCT/EP2010/051321 patent/WO2010089330A1/en active Application Filing
- 2010-02-03 CA CA2751443A patent/CA2751443C/en active Active
- 2010-02-03 BR BRPI1008227A patent/BRPI1008227A8/pt not_active Application Discontinuation
- 2010-02-03 NZ NZ594210A patent/NZ594210A/xx unknown
- 2010-02-03 PT PT107059867T patent/PT2393477T/pt unknown
- 2010-02-03 ES ES10705986.7T patent/ES2659328T3/es active Active
- 2010-02-03 NO NO10705986A patent/NO2393477T3/no unknown
- 2010-02-03 UA UAA201110621A patent/UA102587C2/ru unknown
- 2010-02-03 CN CN201080006616XA patent/CN102307567A/zh active Pending
- 2010-02-03 EP EP10705986.7A patent/EP2393477B1/en not_active Revoked
- 2010-02-03 SG SG2011056207A patent/SG173538A1/en unknown
- 2010-02-03 KR KR1020117017903A patent/KR20110122671A/ko active Search and Examination
- 2010-02-03 HU HUE10705986A patent/HUE038553T2/hu unknown
- 2010-02-03 AU AU2010210183A patent/AU2010210183B2/en active Active
- 2010-02-03 EP EP17206605.2A patent/EP3338782A1/en active Pending
- 2010-02-03 SI SI201031650T patent/SI2393477T1/en unknown
- 2010-02-03 RU RU2011135824/15A patent/RU2519344C2/ru active
- 2010-02-03 CN CN201410371150.3A patent/CN104306360A/zh active Pending
- 2010-02-03 PL PL10705986T patent/PL2393477T3/pl unknown
- 2010-02-03 MX MX2011008200A patent/MX2011008200A/es active IP Right Grant
- 2010-02-03 DK DK10705986.7T patent/DK2393477T3/en active
- 2010-02-03 JP JP2011548677A patent/JP5886630B2/ja active Active
-
2011
- 2011-07-06 IL IL213959A patent/IL213959A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20100196483A1 (en) | 2010-08-05 |
| MX2011008200A (es) | 2011-10-21 |
| KR20110122671A (ko) | 2011-11-10 |
| JP5886630B2 (ja) | 2016-03-16 |
| NO2393477T3 (pt) | 2018-05-26 |
| BRPI1008227A2 (pt) | 2016-03-08 |
| AU2010210183B2 (en) | 2014-09-11 |
| JP2012516873A (ja) | 2012-07-26 |
| CA2751443A1 (en) | 2010-08-12 |
| PL2393477T3 (pl) | 2018-06-29 |
| CN102307567A (zh) | 2012-01-04 |
| SG173538A1 (en) | 2011-09-29 |
| EP2393477B1 (en) | 2017-12-27 |
| UA102587C2 (ru) | 2013-07-25 |
| AU2010210183A1 (en) | 2011-07-28 |
| EP2393477A1 (en) | 2011-12-14 |
| SI2393477T1 (en) | 2018-04-30 |
| BRPI1008227A8 (pt) | 2018-12-11 |
| IL213959A0 (en) | 2011-08-31 |
| CN104306360A (zh) | 2015-01-28 |
| WO2010089330A1 (en) | 2010-08-12 |
| EP3338782A1 (en) | 2018-06-27 |
| ES2659328T3 (es) | 2018-03-14 |
| CA2751443C (en) | 2018-03-20 |
| PT2393477T (pt) | 2018-02-14 |
| RU2519344C2 (ru) | 2014-06-10 |
| HUE038553T2 (hu) | 2018-10-29 |
| IL213959A (en) | 2015-05-31 |
| NZ594210A (en) | 2013-09-27 |
| RU2011135824A (ru) | 2013-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2393477T3 (en) | APPLICATION OF A GLUCOCORTICOID COMPOSITION FOR TREATMENT OF HEAVY AND UNCONTROLLED ASTMA | |
| US8668901B2 (en) | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma | |
| JP5372028B2 (ja) | 薬剤投与システム | |
| AU2006202869B2 (en) | Improvements in and relating to controlling drug delivery apparatus | |
| US8834848B2 (en) | Flow and volume regulated inhalation for treatment of severe oral corticosteroid-dependent asthma | |
| EP2482903B1 (en) | Improved method for treatment of patients with cystic fibrosis | |
| US20100092397A1 (en) | Method For Treatment of COPD and Other Pulmonary Diseases | |
| JP2010088864A (ja) | ヘリオックスを用いるエアロゾル化した薬物の吸入のための医療デバイス | |
| WO2006036181A1 (en) | Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients | |
| Ariyananda et al. | Aerosol delivery systems for bronchial asthma | |
| Berger et al. | Particle size and small airway effects of mometasone furoate delivered by dry powder inhaler. | |
| Scichilone et al. | Revising old principles of inhaled treatment in new fixed combinations for asthma | |
| Kantar | What Makes Flunisolide Different Among Inhaled Corticosteroids Used for Nebulization | |
| Alberts et al. | Effect of Aerosol Devices and Administration Techniques on Drug Delivery in a Simulated Spontaneously Breathing Pediatric Tracheostomy Model | |
| Rush | Aerosolized drugs. | |
| CN110664819A (zh) | 供吸入的齐墩果酸制剂及其制备方法与医药用途 | |
| Sly | Aerosol therapy in Australia |